Skip to main content
. 2009 Dec 30;7(2):125–137.

Table 7.

Odds ratios (ORs) and 95% confidence intervals (95% CIs) for herb use and TCAM use, bivariate and multivariate analyses

Bivariate analyses Multivariate analyses
Herb use TCAM use Herb use TCAM use
Variable % Cr OR (95% CI) P % Cr OR (95%
CI)
P Adj OR
(95% CI)
P Adj OR (95% CI) P
Sex
Female (n=370)
Male (n=139)
7.2
10.6
1.00 (reference)
1.53 (0.71–3.01)
.22 30.5
22.0
1.00
0.64 (0.40–1.03)
.06 --- ---
Age in years
Not using (herbs or TCAM)
Using (herbs or TCAM)
36.8(9.9)
34.5(9.1)
1.00
0.98 (0.95–1.02)
.26 36.3(9.8)
34.5(9.1)
1.00
0.97 (0.95–1.00)
.02 --- 1.00
0.98 (0.96–1.01)
.156
Educational level
Low (None-up to Grade 7)
High (Grade 8 or more)
6.1
8.6
1.00
1.45 (0.72–2.93)
.301 20.9
31.7
1.00
1.76 (1.16–2.67)
.008 --- 1.00
1.67 (1.03–2.78)
.049
Residence
Rural (n=388)
Urban (n=227)
9.8
5.1
0.39(0.18–0.88) .02 30.0
24.4
1.00
0.71 (0.46–1.10)
.13 1.00
1.04 (0.44–2.48)
.927 ---
Employed
No
Yes
9.3
4.4
1.00
0.45 (0.17–1.17)
.099 26.0
32.7
1.00
1.38 (0.88–2.18)
1.62 --- ---
Being on a disability grant
(chronic illness including AIDS)
(n=128)
No
Yes
5.0
10.9
1.00
2.34 (1.16–4.67)
.02 30.1
25.7
1.00
0.80 (0.54–1.18)
.26 1.00
2.45 (1.11–5.41)
.026 ---
Having a health insurance
No
Yes
9.0
2.6
1.00
0.27 (0.06–1.15)
.08 28.7
22.4
1.00
0.71 (0.40–1.27)
.26 ---
CD4 count
≤200
>200
9.1
2.4
1.00
0.24 (0.06–1.03)
.06 26.7
33.3
1.00
1.37 (0.83–2.27)
.22 ---
Time since HIV diagnosis
2006-1995
2007/8
8.9
7.2
1.00
0.79 (0.38–1.64)
.53 32.0
25.7
1.00
0.74 (0.47–1.15)
.18 ---
Hospital admission in past 6
months
No
Yes
8.0
7.5
1.00
0.93 (0.32–2.73)
.90 28.2
24.5
1.00
0.83 (0.43–1.60)
.57 ---
Number of HIV symptoms
Not using (herbs or TCAM)
Using (herbs or TCAM)
M(SD)
1.21(2.4)
1.25(4.2)
1.00
1.01 (0.89–1.14)
.93 M(SD
1.20(2.5)
1.28(3.0)
1.01 (0.94–1.09) .77 ---
Overall Quality of Life (range 1–5)
Not using (herbs or TCAM)
Using (herbs or TCAM)
4.4(0.7)
4.0(0.4)
1.00
0.49 (0.33–0.73)
.000 4.4 (0.7)
4.1 (0.6)
1.00
0.50 (0.37–0.67)
.000 1.00
0.97 (0.50–1.89)
.937 1.00
0.59 (0.42–0.83)
.003
Missed medication to avoid side
effects
No
Yes
5.7
35.9
1.00
9.23 (4.31–19.75)
.000 26.0
48.7
1.00
2.70 (1.40–5.23)
.003 1.00
3.00 (1.24–7.22)
.014 1.00
1.87 (0.85–4.14)
.121
Suspended ART because of side
effects
No
Yes
7.6
13.0
1.00
1.83 (0.52–6.44)
.347 27.6
27.3
1.00
0.99 (0.38–2.57)
.975 --- ---
Understanding of T-helper
(CD4) count
No or some
Yes
4.1
9.9
1.00
2.53 (1.09–5.84)
.030 35.7
24.0
1.00
0.57 (0.38–0.85)
.006 1.00
0.96 (0.35–2.64)
.934 1.00
0.54 (0.33–0.89)
.016
HIV disease & HIV treatment
related knowledge (better
informed than most)
No
Yes
3.3
9.0
1.00
3.03 (1.06–8.68)
.039 9.0
33.9
1.00
5.17 (2.68–9.94)
.000 1.00
0.21 (0.04–1.10)
.064 1.00
3.25 (1.51–7.01)
.003
Information involvement score
Low
High
17.1
1.9
1.00
0.10 (0.04–0.23)
.000 37.7
21.5
1.00
0.45 (0.31–0.67)
.000 1.00
0.50 (0.12–2.07)
.337 1.00
0.97 (0.52–1.83)
.930
Degree of trust in medical
provider score
Low
High
16.3
1.7
1.00
0.09 (0.03–0.23)
.000 37.7
20.6
1.00
0.43 (0.29–0.64)
.000 1.00
0.39 (0.08–2.01)
.259 1.00
1.21 (0.64–2.30)
.555
Decision involvement score
Low
1.7 1.00 17.4 1.00 1.00 1.00
High 16.0 10.84 (4.17–28.18) .000 41.6 3.37 (2.24–5.06) .000 2.50 (0.63–9.96) .195 3.71 (2.02–6.82) .000
Discrimination by care provider
No
7.7 1.00 28.0 1.00 --- ---
Yes 14.3 2.00 (0.43–9.29) .374 21.4 0.70 (0.19–2.55) .588
Seen ARV treatment buddy
No
2.4 1.00 25.6 1.00 1.00 1.00
Yes 24.4 13.36 (6.17–28.91 .000 34.6 1.54 (1.00–2.36) .049 5.27 (0.54–51.15) .152 0.70 (0.16–3.14) .641
Seen someone for
counselling/support
No
2.6 1.00 25.5 1.00 1.00 1.00
Yes 25.2 12.80 (6.06–27.06) .000 35.2 1.59 (1.03–2.46) .037 0.85 (0.10–7.49) .846 0.65 (0.14–2.96) .575
Nagelkerke R Square .34 .23